Intezyne Technologies
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3802 Spectrum Blvd Ste 202, Tampa, Flori...Phone Number
(813) 910-2120Website
www.intezyne.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Intezyne Technologies
Intezyne is focused on developing innovative cancer therapies. The company aims to create breakthrough treatments that address the needs of patients battling cancer. Their services are directed towards healthcare providers and organizations involved in cancer treatment. Intezyne is committed to advancing cancer care through its research and development efforts.Explore more
Intezyne Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Intezyne Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Intezyne Technologies has new funding data
Check if Intezyne Technologies has recently received funding, and reach out quickly before it becomes old news!
Click to see if Intezyne Technologies had a recent Job posting/layoffs
Check out if Intezyne Technologies is spiking on competitors!
Earning: See what the market has to say on Intezyne Technologies recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Intezyne Technologies
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Intezyne Technologies launches new products
Website visits: Recent activity has been detected on your website
Intezyne Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Intezyne Technologies as Masked Content
Find 2 more new buyers
Compare Similar Companies to Intezyne Technologies
Compare insights from companies similar to Intezyne Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Intezyne Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Intezyne Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Intezyne Technologies.
Intezyne Technologies financials insights
Gather financial insights about Intezyne Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$10M
Intezyne Technologies Tech Stack
A closer look at the technologies used by Intezyne Technologies
Most Recent Scoops
Left Company
Executive Move
Suzanne Bakewell, Vice President, Preclinical Development, has left the organization.
Executive Moves, Personnel Moves, Left Company
Award
E. McAllister, President & Chief Executive Officer has been named a 2018 CFO of the Year honoree.
Award
Promotion
Executive Move
Intezyne Technologies has promoted Adam Carie to Director, Product Development. In this role, Carie will be responsible for product development opportunities, external development relationship management, and internal product candidate formulation.
Executive Moves, Promotion
Promotion
Executive Move
Executive Moves, Promotion
Intezyne Technologies News & Media
Data Showing that IT-139 Triggers Immunogenic Cell Death (ICD) to Be Presented at AACR 2018 Annual Meeting
TAMPA, Fla., April 13, 2018 /PRNewswire/ -- Intezyne, a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, announced that the University of Vienna are presenting data showing IT-139's induction of Immunogenic Cell Death (ICD) at the American Association...Combination of Checkpoint Inhibitors and Intezyne's Novel Cancer Resistance Pathway Inhibitor IT-139 Shows Enhanced Immune Efficacy
TAMPA, Fla., April 10, 2018 /PRNewswire/ -- Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced exciting results from their ongoing preclinical studies of novel cancer resistance pathway inhibitor IT-139 in combination with immune...Intezyne Promotes Adam Carie, PhD to Director, Product Development
TAMPA, Fla., April 9, 2018 /PRNewswire/ -- Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has promoted Adam Carie, PhD to Director, Product Development. In his new role, Dr. Carie will help identify compelling product...Intezyne Promotes Bradford Sullivan, PhD to Director, CMC
TAMPA, Fla., April 9, 2018 /PRNewswire/ -- Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has promoted Bradford Sullivan, PhD to Director, Chemistry, Manufacturing, and Controls (CMC). In his new capacity, Dr. Sullivan will...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intezyne Technologies
Sign Up For FreeTo access detailed company insights
Intezyne is focused on developing innovative cancer therapies. The company aims to create breakthrough treatments that address the needs of patients battling cancer. Their services are directed towards healthcare providers and organizations involved in cancer treatment. Intezyne is committed to advancing cancer care through its research and develop... Read More
